PALBOPRO 125MG CAPSULE

About PALBOPRO 125MG CAPSULE

Palbopro 125MG Capsule contains palbociclib 125mg. It blocks CDK4 and CDK6, proteins that push hormone-sensitive breast cancer cells to divide, which is why it is classed as a CDK4/6 inhibitor (targeted therapy). Specialists use it for hormone receptor-positive, HER2-negative advanced breast cancer, with an aromatase inhibitor or fulvestrant. During treatment expect regular checks such as blood counts before each cycle. Made by RPG Life Sciences; pack size 21 capsules. MRP Rs 2,720 as per the NPPA revision of 9 November 2026. Never start, stop or change it on your own - the oncologist or specialist decides the plan.